semaglutide cardiovascular indication 🔴Cardiovascular outcomes with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants Semaglutide Effects on Cardiovascular Outcomes
Description
Conflicts of interest M.C
Your prescriber will advise which medications to continue and which to pause according to local policy
A stye is an acute, localized infection of an eyelid gland, often presenting as a painful, red bump near the lid margin
It works by mimicking the GLP-1 hormone to regulate appetite and blood sugar levels
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which typically diminish over time with continued use
Medication will arrive in 3 shipments, sent every 60 days with injection kit (includes needles, syringes & alcohol swabs)
